Seelos Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Seelos Therapeutics is scheduled to report earnings on April 26, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 419.00K	$ 875.00K	$ 40.00K	$ 0.00	$ 0.00
Gross Profit	$ 419.00K	$ 875.00K	$ 40.00K	-	-
EBIT	$ -29.49M	$ -9.19M	$ -15.64M	$ -19.60M	$ -21.27M
EBITDA	$ -29.48M	$ -9.18M	$ -15.59M	$ -19.60M	$ -21.27M
Net Income Common Stockholders	$ -29.50M	$ -13.43M	$ -18.66M	$ -19.60M	$ -21.27M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 5.80M	$ 14.10M	$ 15.50M	$ 30.51M	$ 41.25M
Total Assets	$ 11.85M	$ 23.68M	$ 22.75M	$ 40.51M	$ 52.67M
Total Debt	$ 15.34M	$ 16.78M	$ 20.12M	$ 21.40M	$ 19.27M
Net Debt	$ 9.54M	$ 2.68M	$ 4.62M	$ -9.11M	$ -21.98M
Total Liabilities	$ 59.07M	$ 44.30M	$ 33.36M	$ 32.63M	$ 26.44M
Stockholders Equity	$ -47.21M	$ -20.68M	$ -10.61M	$ 7.88M	$ 26.23M
Cash Flow	-
Free Cash Flow	$ -5.90M	$ -10.35M	$ -13.09M	$ -11.07M	$ -20.39M
Operating Cash Flow	$ -5.90M	$ -10.35M	$ -13.09M	$ -11.07M	$ -20.39M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ -2.31M	$ 8.87M	$ -1.89M	$ 334.00K	$ -126.00K

Currency in USD

Seelos Therapeutics Earnings and Revenue History

Income Statement >

Seelos Therapeutics Debt to Assets

Balance Sheet >

Seelos Therapeutics Cash Flow

Cash Flow >

Seelos Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing